Stocks and Investing Stocks and Investing
Wed, November 17, 2021
Tue, November 16, 2021

Brian Abrahams Maintained (ATAI) at Hold with Decreased Target to $17 on, Nov 16th, 2021


Published on 2024-10-27 18:40:37 - WOPRAI, Brian Abrahams
  Print publication without navigation


Brian Abrahams of RBC Capital, Maintained "Atai Life Sciences N.V." (ATAI) at Hold with Decreased Target from $19 to $17 on, Nov 16th, 2021.

Brian has made no other calls on ATAI in the last 4 months.



There are 4 other peers that have a rating on ATAI. Out of the 4 peers that are also analyzing ATAI, 0 agree with Brian's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Brian


  • Elemer Piros of "Roth Capital" Initiated at Strong Buy and Held Target at $32 on, Thursday, November 11th, 2021
  • Patrick Trucchio of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $40 on, Monday, October 18th, 2021
  • Andrew Tsai of "Jefferies" Initiated at Strong Buy and Held Target at $27 on, Wednesday, September 1st, 2021
  • Nathan Weinstein of "Argus Research" Maintained at Strong Buy with Increased Target to $27 on, Tuesday, August 17th, 2021
Contributing Sources